VolitionRx Limited Operating Lease, Liability, Noncurrent
VolitionRx Limited (VNRX) had Operating Lease, Liability, Noncurrent of $157.48 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-13
- 2026-06-30: Operating Lease, Liability, Noncurrent $157.48K.
- 2026-03-31: Operating Lease, Liability, Noncurrent $208.66K.
- 2025-12-31: Operating Lease, Liability, Noncurrent $276.56K.
- 2025-09-30: Operating Lease, Liability, Noncurrent $351.21K.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $157.48K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $208.66K 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $276.56K 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $351.21K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $417.01K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $369.34K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $410.69K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $448.05K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $350.81K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $396.38K 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $378.05K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $323.96K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $340.31K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $381.72K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $400.09K 10-K · filed 2024-03-25 | |
| 2022-09-30 | $449.33K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $519.49K 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $594.39K 10-Q · filed 2022-05-11 | |
| 2021-12-31 | $217.31K 10-K · filed 2023-03-15 | $171.17K 10-K · filed 2022-03-30 |
| 2021-09-30 | $144.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $166.09K 10-Q · filed 2021-08-11 | |
| 2021-03-31 | $142.01K 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $179.62K 10-K · filed 2022-03-30 | $151.83K 10-K · filed 2021-03-22 |
| 2020-09-30 | $108.31K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $78.50K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $112.21K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $131.88K 10-K · filed 2021-03-22 | |
| 2019-06-30 | $100.03K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $50.35K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |